Latest Health News
WHO Extends Polio PHEIC After Emergency Committee Meeting
The WHO Director-General determined on March 1, 2026, that the poliovirus situation with WPV1 and cVDPV continues as a public health emergency of international concern. Novel OPV2 (nOPV2) has shown genetic stability, interrupting over 80% of cVDPV2 outbreaks with few campaigns, but risks rise with suboptimal vaccination. New cVDPV1 and cVDPV3 outbreaks in multiple countries highlight immunity gaps and low routine immunization.
Liberate Bio Licenses Myeloid-Optimized CAR Designs for In Vivo CAR-M
Liberate Bio secured exclusive and non-exclusive licenses from Carisma Therapeutics and University of Pennsylvania for CAR designs targeting myeloid cells like monocytes and macrophages. This advances their genetic medicines delivering RNA therapies directly to immune cells. Announcement made on March 5, 2026.
HeartBeam Starts Patient Enrollments in Heart Attack Detection Pilot
HeartBeam announced first patient enrollments in a pilot study for heart attack detection using their technology. The study aims to improve early detection of cardiac events. Released on March 5, 2026.
Immunis Licenses KORA for Parkinson's Disease Dyskinesia Treatment
Immunis entered an exclusive licensing agreement with Toray for drug candidate IMM02-KORA to treat dyskinesia in Parkinson's patients. They hold exclusive rights for development and commercialization in the US. Announced March 5, 2026.
Zura Bio Presents Phase 2 Study Design for Systemic Sclerosis Drug
Zura Bio's Phase 2 TibuSURE trial design for tibulizumab (ZB-106), inhibiting IL-17A and BAFF, accepted for poster at Systemic Sclerosis World Congress. Targets autoimmune inflammatory diseases. Presented March 5, 2026.
England Releases Rare Diseases Action Plan 2026 Progress Report
The plan highlights MHRA reforms, NICE quality standards, NHS framework for individualized genetic therapies, and pilot centers for undiagnosed rare conditions. NHS Genomic Medicine Service covers over 7,000 rare diseases; Generation Study pilots whole genome sequencing for newborns. Aims to cut diagnosis time from 4 years to 3 months via 10 Year Health Plan.
Joint Commission Updates Sentinel Event System for Surgical Safety
New framework aligns with 2025 NQF Serious Reportable Events list of 28 events, standardizing reporting across care settings including ambulatory centers. Emphasizes learning from near-misses and system failures, not blame, with clinical guidance for reviews. Enhances consistency for surgeons.
World Obesity Federation Warns of 220M Obese Children by 2040
Report projects over 220 million children could be obese by 2040, with India ranking second globally in childhood obesity per recent study. U.S. sees rising cases alongside measles outbreaks affecting children. Advocacy needed for prevention.
EU Health Package Reforms Biotech and Clinical Trials for 2026
European Commission's Health Package advances biotech reforms and streamlines clinical trials to boost innovation. Focuses on faster approvals and better access. Announced March 5, 2026.
Hearing Aid Tech in 2026 Integrates AI and Biometrics
2026 hearing aids feature advanced AI for real-time sound adjustments, biometric sensors tracking health metrics like stress and activity, smaller eco-friendly designs, and Auracast for public audio streaming. Reduces stigma and enhances well-being.
HIV Researchers Highlight Breakthroughs at CROI 2026
Experts at CROI 2026 discuss innovative therapies, global care strategies, and challenges in HIV management. Emphasizes lessons for worldwide impact.
UK Webinar Addresses SRHR Funding Cuts Impacting UHC
GLN webinar examines shrinking health aid, cuts in Africa, and political pushback on sexual reproductive health rights undermining women's and children's health progress toward universal health coverage. Scheduled March 5, 2026.